description Patrick Soon-Shiong Overview
Patrick Soon-Shiong is a South African-born American surgeon, physician, biomedical entrepreneur, and medical researcher. He developed nab-paclitaxel, marketed as Abraxane, an albumin-bound formulation of paclitaxel used in cancer treatment. His work connects clinical surgery with drug development and biotechnology, particularly in oncology. He is also known for founding and leading companies built around medical research and healthcare technology, making him a prominent physician involved in commercial biomedical development.
help Patrick Soon-Shiong FAQ
What cancer drug did Patrick Soon-Shiong develop?
Patrick Soon-Shiong developed nab-paclitaxel, an albumin-bound formulation of paclitaxel. It is marketed under the brand name Abraxane and used in cancer treatment.
What is Abraxane made from?
Abraxane is based on paclitaxel, a cancer-treatment drug, but uses an albumin-bound formulation. This formulation connects Soon-Shiong's biomedical research with clinical oncology.
What is Patrick Soon-Shiong's medical background?
He is a South African-born American surgeon, physician, biomedical entrepreneur, and medical researcher. His work combines clinical surgery with drug development and biotechnology.
Why is nab-paclitaxel important in Patrick Soon-Shiong's career?
Nab-paclitaxel is the development most closely associated with his biomedical career. The drug is marketed as Abraxane and is used in cancer treatment.
explore Explore More
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
